New Studies in Japan and Austria Tout Benefits of Juice Plus +®

Scientists around the world continue to demonstrate in clinical investigations the healthful benefits of taking Juice Plus +®.

Two recently published studies – from investigators at Tokyo Women's Medical University and the Medical University of Graz in Austria – are the latest examples.

Tokyo Women's Medical University (Japan)

The Tokyo study reinforced earlier findings in three important areas: the bioavailability of key antioxidants in the bloodstream after taking Juice Plus +®; a reduction in levels of homocysteine, a potential risk factor for heart attack and stroke; and a reduction in lipid peroxides, which are a key indicator of the oxidative stress that is thought to contribute to premature aging and degenerative disease.

Medical University of Graz (Austria)

The Graz study involved 41 anti-terrorist policemen (average age 34) in the Austrian Special Forces “Cobra” unit. It was conducted over a 28-week period between November 2005 and June 2006 in a cold, alpine climate. The results reinforced earlier findings in two important areas: a reduction in a marker of exercise-induced oxidative stress first seen in a previous clinical study of Juice Plus +® at the University of North Carolina-Greensboro; and an improvement in a key indicator of immunity called TNF-alpha.

A Growing Body of Scientific Evidence

The Tokyo and Graz studies are just the latest in a growing body of peer-reviewed, published clinical studies on Juice Plus +® – 13 published studies with 11 more underway. The results from the two latest are especially impressive, says John Blair, Vice-President of Product and Research for Juice Plus +®.

”Like most clinical investigations of Juice Plus +® – and all of those started since 2001 – the Tokyo and Graz studies were ‘gold standard’– randomized, double-blind, and placebo- controlled. Both were especially telling, in that otherwise healthy, younger adults achieved similar positive results from taking Juice Plus +® as we've already seen in other populations.”

For a complete review of these clinical investigations, please visit: